These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15732264)

  • 1. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.
    Lo AC; Hadjimichael O; Vollmer TL
    Mult Scler; 2005 Feb; 11(1):33-40. PubMed ID: 15732264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
    Hadjimichael O; Vollmer T; Oleen-Burkey M;
    Health Qual Life Outcomes; 2008 Nov; 6():100. PubMed ID: 19014588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts.
    Culpepper WJ; Wallin MT; Magder LS; Perencevich E; Royal W; Bradham DD; Cutter G; Bever CT
    J Rehabil Res Dev; 2015; 52(3):263-72. PubMed ID: 26220064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of multiple sclerosis relapse: The NARCOMS participant perspective.
    Nickerson M; Cofield SS; Tyry T; Salter AR; Cutter GR; Marrie RA
    Mult Scler Relat Disord; 2015 May; 4(3):234-40. PubMed ID: 26008940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of clinical characteristics for 'benign' multiple sclerosis.
    Ramsaransing GS; De Keyser J
    Eur J Neurol; 2007 Aug; 14(8):885-9. PubMed ID: 17662009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course of progressive multiple sclerosis in Brazilian patients.
    Vasconcelos CC; Miranda-Santos CM; Alvarenga RM
    Neuroepidemiology; 2006; 26(4):233-9. PubMed ID: 16707908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study.
    Di Rezze S; Frasca V; Inghilleri M; Durastanti V; Cortese A; Giacomelli E; Millefiorini E
    Clin Neuropharmacol; 2012; 35(5):231-4. PubMed ID: 22751087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
    Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
    Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized crossover study of bee sting therapy for multiple sclerosis.
    Wesselius T; Heersema DJ; Mostert JP; Heerings M; Admiraal-Behloul F; Talebian A; van Buchem MA; De Keyser J
    Neurology; 2005 Dec; 65(11):1764-8. PubMed ID: 16221950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
    Skierlo S; Rommer PS; Zettl UK
    Acta Neurol Scand; 2017 Apr; 135(4):394-399. PubMed ID: 27283842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and treatment of spasticity reported by multiple sclerosis patients.
    Rizzo MA; Hadjimichael OC; Preiningerova J; Vollmer TL
    Mult Scler; 2004 Oct; 10(5):589-95. PubMed ID: 15471378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.
    Fox RJ; Bacon TE; Chamot E; Salter AR; Cutter GR; Kalina JT; Kister I
    Neurodegener Dis Manag; 2015; 5(6 Suppl):3-10. PubMed ID: 26611264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis in Pakistan.
    Wasay M; Ali S; Khatri IA; Hassan A; Asif M; Zakiullah N; Ahmed A; Malik A; Khealani B; Haq A; Fredrikson S
    Mult Scler; 2007 Jun; 13(5):668-9. PubMed ID: 17548448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
    Fricska-Nagy Z; Füvesi J; Rózsa C; Komoly S; Jakab G; Csépány T; Jobbágy Z; Lencsés G; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2016 May; 7():26-32. PubMed ID: 27237753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue, depression and progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
    Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of neuropathic pain in early multiple sclerosis.
    Heitmann H; Biberacher V; Tiemann L; Buck D; Loleit V; Selter RC; Knier B; Tölle TR; Mühlau M; Berthele A; Hemmer B; Ploner M
    Mult Scler; 2016 Aug; 22(9):1224-30. PubMed ID: 26480924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal correlates of fatigue in multiple sclerosis.
    Patrick E; Christodoulou C; Krupp LB;
    Mult Scler; 2009 Feb; 15(2):258-61. PubMed ID: 19181775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of a multicenter study of Rebif-22 mcg administration in Russia].
    Zavalishin IA; Gusev EI; Iakhno NN; Skoromets AA; Boĭko AN; Demina TL; Burlutskiĭ A P ; Beĭn BN; Sholomov II; Pereserdova AV; Stoĭda NI; Zakharova MN; Adarcheva LS; Niiazbekova AS; Askarova LSh; Oleĭnikov VG; Rebrova OIu; Shmidt TE; Davydovskaia MV; Totolian NA; Beskhmel'nitsina IA; Bragina OV; Ponomareva GL; Durseneva OM; Voronchikhina SA; Volkova LI; Turova EL; Streknev AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):73-8. PubMed ID: 12938639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.